z-logo
open-access-imgOpen Access
Ceftazidime-avibactam and intrapleural amikacin therapy for extensively drug-resistant Pseudomonas aeruginosa thoracic empyema
Author(s) -
Tzu-Ting Chen,
Shumei Chen,
HsinYi Liu
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000029467
Subject(s) - medicine , amikacin , empyema , pseudomonas aeruginosa , ceftazidime , ceftazidime/avibactam , intensive care medicine , surgery , antibiotics , microbiology and biotechnology , bacteria , biology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here